303 related articles for article (PubMed ID: 28952162)
1. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature.
Lowenstein SE; Garrett G; Toland AE; Jambusaria-Pahlajani A; Asgari MM; Green A; Engels EA; Arron ST;
Br J Dermatol; 2017 Nov; 177(5):1202-1207. PubMed ID: 28952162
[TBL] [Abstract][Full Text] [Related]
2. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
3. Keratinocyte cancer and its precursors in organ transplant patients.
Jenni D; Hofbauer GF
Curr Probl Dermatol; 2015; 46():49-57. PubMed ID: 25561206
[TBL] [Abstract][Full Text] [Related]
4. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.
Zamoiski RD; Yanik E; Gibson TM; Cahoon EK; Madeleine MM; Lynch CF; Gustafson S; Goodman MT; Skeans M; Israni AK; Engels EA; Morton LM
Cancer Res; 2017 Aug; 77(15):4196-4203. PubMed ID: 28615224
[TBL] [Abstract][Full Text] [Related]
5. Overview on non-melanoma skin cancers in solid organ transplant recipients.
Forchetti G; Suppa M; Del Marmol V
G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
[TBL] [Abstract][Full Text] [Related]
6. Management of non-melanoma skin cancer in solid organ transplant recipients.
Specchio F; Saraceno R; Chimenti S; Nistico S
Int J Immunopathol Pharmacol; 2014; 27(1):21-4. PubMed ID: 24674675
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of keratinocyte carcinomas after organ transplantation.
Madeleine MM; Patel NS; Plasmeijer EI; Engels EA; Bouwes Bavinck JN; Toland AE; Green AC;
Br J Dermatol; 2017 Nov; 177(5):1208-1216. PubMed ID: 28994104
[TBL] [Abstract][Full Text] [Related]
8. Organ transplantation and skin cancer: basic problems and new perspectives.
Hofbauer GF; Bouwes Bavinck JN; Euvrard S
Exp Dermatol; 2010 Jun; 19(6):473-82. PubMed ID: 20482618
[TBL] [Abstract][Full Text] [Related]
9. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
Tessari G; Girolomoni G
Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
[TBL] [Abstract][Full Text] [Related]
10. The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
Leblanc KG; Hughes MP; Sheehan DJ
Dermatol Surg; 2011 Jun; 37(6):744-9. PubMed ID: 21605234
[TBL] [Abstract][Full Text] [Related]
11. [Skin cancer and other skin disorders in patients following solid organ transplantation].
de Graaf YG; de Fijter JW; Posma AN; Feltkamp MC; Claas FH; Bouwes Bavinck JN
Ned Tijdschr Geneeskd; 2005 Mar; 149(10):511-7. PubMed ID: 15782685
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
Tee LY; Sultana R; Tam SYC; Oh CC
J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631
[No Abstract] [Full Text] [Related]
13. Solar ultraviolet radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs): an update.
Reichrath J
Adv Exp Med Biol; 2014; 810():253-71. PubMed ID: 25207370
[TBL] [Abstract][Full Text] [Related]
14. Management of Cutaneous Cancers in Patients Undergoing Organ Transplantation-Part I: Current Status: Reactive Approach.
Sharma D; Handler MZ; Shah R; Weiss A; Lambert MW; Gagna CE; Lambert WC
Skinmed; 2017; 15(5):329-331. PubMed ID: 29139358
[No Abstract] [Full Text] [Related]
15. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
[TBL] [Abstract][Full Text] [Related]
17. The mTOR-inhibitor Sirolimus decreases the cyclosporine-induced expression of the oncogene ATF3 in human keratinocytes.
Schaper-Gerhardt K; Walter A; Schmitz-Rode C; Satzger I; Gutzmer R
J Dermatol Sci; 2018 Nov; 92(2):172-180. PubMed ID: 30220530
[TBL] [Abstract][Full Text] [Related]
18. Iatrogenic immunosuppression and cutaneous malignancy.
DePry JL; Reed KB; Cook-Norris RH; Brewer JD
Clin Dermatol; 2011; 29(6):602-13. PubMed ID: 22014982
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study.
Bouwes Bavinck JN; Feltkamp MCW; Green AC; Fiocco M; Euvrard S; Harwood CA; Nasir S; Thomson J; Proby CM; Naldi L; Diphoorn JCD; Venturuzzo A; Tessari G; Nindl I; Sampogna F; Abeni D; Neale RE; Goeman JJ; Quint KD; Halk AB; Sneek C; Genders RE; de Koning MNC; Quint WGV; Wieland U; Weissenborn S; Waterboer T; Pawlita M; Pfister H;
Am J Transplant; 2018 May; 18(5):1220-1230. PubMed ID: 29024374
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients.
Herman S; Rogers HD; Ratner D
Skinmed; 2007; 6(5):234-8. PubMed ID: 17786101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
